The Genetics of SLC12A6

While the physical symptoms of Andermann syndrome are what you see every day, the root cause lies deep within your child’s genetic code. Understanding the SLC12A6 gene and how it functions can help you make sense of why this condition affects so many different parts of the body.

The Role of the KCC3 Transporter

Every cell in the body needs to maintain a delicate balance of salt and water to function correctly. The SLC12A6 gene provides the instructions for making a protein called KCC3.

Think of KCC3 as a specialized transporter on the surface of nerve cells (neurons) ^[1]. Its job is to move potassium and chloride out of the cell together ^[2]. This process is vital for two main reasons:

1. Cell Volume Control: By moving salts out, the transporter helps the cell regulate its size. It is believed that without a working transporter, nerve cells can swell, which eventually leads to damage and degeneration ^[3][4].
2. Electrical Signals: Proper salt levels are necessary for nerves to maintain the excitability needed to send the electrical “messages” that tell muscles to move and skin to feel touch ^[5].

Autosomal Recessive Inheritance

Classic Andermann syndrome is an autosomal recessive condition. This means that for a child to have the syndrome, they must inherit two pathogenic (disease-causing) copies of the SLC12A6 gene—one from their mother and one from their father ^[6][7].

• Carriers: Parents of a child with the recessive form are typically “carriers.” They have one working copy of the gene and one pathogenic copy. Carriers generally do not have classic recessive Andermann syndrome because their one working gene produces enough KCC3 to keep their nerves healthy ^[8].
• Recurrence Risk: For two carrier parents, there is a 25% (1 in 4) chance with each pregnancy that the child will inherit both mutated genes and have the syndrome ^[9]. There is a 50% chance the child will be a carrier like the parents, and a 25% chance the child will inherit two working genes. This risk applies independently to every pregnancy.

The “Intact” Corpus Callosum

One of the most confusing aspects of this diagnosis is its name: “Corpus Callosum Agenesis-Neuronopathy Syndrome.” This name suggests that the bridge between the two halves of the brain (the corpus callosum) must be missing (agenesis) ^[7].

However, modern research has shown that this is not always true. You can have Andermann syndrome even if the corpus callosum is completely intact and appears normal on an MRI ^[6][7]. Doctors have identified children with the exact same genetic mutations and nerve symptoms who have perfectly formed brain structures ^[6]. Because of this, a “normal” brain scan does not rule out the diagnosis if the genetic testing and nerve symptoms match.

Recessive vs. Emerging Heterozygous Phenotypes

It is important to discuss your child’s specific genetic report with a clinical geneticist. While Andermann syndrome requires two pathogenic variants (biallelic), limited emerging evidence has shown that some specific, rare pathogenic variants in just one copy of the gene (heterozygous) might cause a different, later-onset sensory-predominant neuropathy in some families ^[10][8].

This dominant neuropathy is rare, variant-specific, and still being characterized by researchers. It typically does not involve the brain or intellectual disability. A simple heterozygous finding (one variant) on a genetic test should NOT be immediately labeled as a dominant disease; it may simply represent carrier status, or it could mean a second mutation is hiding and requires deeper genetic testing (like deletion/duplication analysis) to find. Relatives should be directed to a genetics professional for individualized counseling rather than assuming broad risk or broad reassurance.